What this guide covers
The blind spots in FDA-only monitoring
Watching one regulator leaves gaps for three reasons:
- Signals appear in one country first. A field safety corrective action often shows up with one regulator before the others. A competitor's recall in Canada, or an MHRA field safety notice, can be your earliest warning about a component or device type you share.
- The publications don't line up. Each regulator has its own document types: adverse-event databases like MAUDE, field safety notices, national recall lists and rapid-alert systems. None of them republishes the others.
- Your obligations cover more than one country. If you hold a UKCA or CE mark, or sell into Canada or Switzerland, your post-market surveillance plan should cover signals from those markets. An EU MDR PMS plan that only cites US data is a gap an auditor can find. (See our guide to EU MDR Articles 83–92.)
openFDA (United States)
The US remains the deepest public source: adverse events (MAUDE), recalls and enforcement reports, 510(k)/PMA clearances, and the GUDID device registry. Much of it is available through the openFDA APIs. It's the base of most monitoring programmes, and our separate guide covers how to monitor FDA MAUDE in depth. This article is about what the FDA doesn't cover, which is everything below.
MHRA (United Kingdom)
The Medicines and Healthcare products Regulatory Agency publishes device safety information and field safety notices (the notices manufacturers issue with field safety corrective actions in the UK), along with device alerts and recall information. Since Brexit, the UK has run its own regulatory system, so UK signals no longer arrive with EU ones. If you hold UKCA marking or sell through UK distributors, MHRA publications are a primary source, not a duplicate of EU data. See our dedicated guide to MHRA field safety notices and device alerts for how to monitor them.
Health Canada
Health Canada maintains a national recalls and safety alerts database covering medical devices, and publishes medical device incident data. Canadian recalls often cover different devices and lots from the equivalent US action, and sometimes come first. If you hold Canadian licences, this data also feeds your mandatory problem reporting. Class II to IV licence holders must also tell Health Canada within 72 hours when a regulator abroad recalls their device or flags a serious risk, which we cover in our guide to Health Canada's foreign risk notification rule.
EU Safety Gate
Safety Gate is the EU's rapid alert system for dangerous non-food consumer products. Medical devices sit under their own vigilance rules, so it rarely carries device alerts, and what does appear tends to be consumer-grade items such as thermometers or toy medical sets. It is worth a watch for products sold to consumers outside normal medical distribution, but for EU device signals the primary sources are national competent authority notices and EUDAMED.
Swissmedic
Switzerland sits outside the EU regulatory system, and since the lapse of the EU-Swiss mutual recognition agreement for medical devices, it has operated its own regime. Swissmedic publishes recalls and field safety corrective actions affecting the Swiss market. For manufacturers selling into Switzerland, these publications are the official national record. They can also give early warning of actions that later spread to other countries. Since 1 July 2026, devices sold in Switzerland must also be registered in swissdamed, the Swiss device database, with a transition period to 31 December 2026. See our guide to swissdamed and Swissmedic's 2026 PMS review.
EUDAMED
EUDAMED is the EU's central medical-device database under the MDR, spanning actor registration, UDI/device registration, certificates, vigilance and market surveillance. It is being switched on module by module. Since 28 May 2026, actor registration, UDI/device registration, notified-body certificates and market surveillance have been mandatory. Legacy devices must be registered by 28 November 2026. The vigilance module is not yet mandatory, and most forecasts expect it in 2027. The public data is already worth watching: device and certificate registrations are visible, and as the vigilance module is switched on it will become a main source of EU-wide safety information. Adding it to your monitoring now saves reworking things later.
Consolidating six sources into one view
Every one of these sources is public, so access isn't the problem. The problem is that they are six different websites, each with its own format, search page and update schedule. Checking them by hand for every device in a real product range takes more time than most teams have, so many end up watching the FDA alone.
An approach that works:
- Collect the data continuously from all six sources into one place, so searches run against current data rather than six live websites.
- Organise it by device. One search for a device or model should show every country's notices side by side.
- Alert on anything new. A new notice that matches your watchlist should reach you as a notification, without anyone having to remember to check.
- Keep the evidence. Log every finding, and keep a hashed copy of the source page where the source allows it. The same data that alerts you then feeds your PMS report or PSUR, with a clear record behind it.
See every source in one lookup
MedFortis consolidates openFDA, MHRA, Health Canada, EU Safety Gate, Swissmedic and EUDAMED, plus a growing set of other national sources, into a single device search, with the evidence behind each finding. See it live against your device lines.
Book a Demo →Key takeaways
- FDA-only monitoring leaves gaps: signals often appear in one country first, and regulators don't republish each other.
- MHRA (UK field safety notices), Health Canada (recalls and incidents), EU Safety Gate (consumer-product alerts, with few device entries), Swissmedic (Swiss recalls and FSCAs) and EUDAMED (the EU's central database, with four modules mandatory since May 2026) each publish things the others don't.
- If your obligations cover several countries, so should your monitoring. An EU MDR PMS plan that cites only US data is an audit gap.
- What works is one view: data collected continuously, search by device, alerts on anything new, and evidence kept. Six browser tabs don't scale.